These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 10526392)

  • 1. [Current therapy of cerebrovascular infarct].
    Lang W; Domanovits H
    Wien Klin Wochenschr; 1999 Sep; 111(17):672-81. PubMed ID: 10526392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.
    Legos JJ; Lenhard SC; Haimbach RE; Schaeffer TR; Bentley RG; McVey MJ; Chandra S; Irving EA; Andrew A Parsons ; Barone FC
    Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroendovascular management of acute ischemic stroke.
    Tjoumakaris SI; Jabbour PM; Rosenwasser RH
    Neurosurg Clin N Am; 2009 Oct; 20(4):419-29. PubMed ID: 19853801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The only evidence based neuroprotective therapy for acute ischemic stroke: thrombolysis.
    Köhrmann M; Schellinger PD; Schwab S
    Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):563-71. PubMed ID: 21619867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Thrombolytic therapy in acute ischemic stroke: present and future].
    Mori E
    No Shinkei Geka; 2003 Mar; 31(3):249-60. PubMed ID: 12684978
    [No Abstract]   [Full Text] [Related]  

  • 6. Ischaemic stroke: acute-phase drug therapy. Mostly aspirin and heparin.
    Prescrire Int; 2005 Aug; 14(78):146-52. PubMed ID: 16106599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of combined therapy with thrombolysis and citicoline in a rat model of embolic stroke.
    Alonso de Leciñana M; Gutiérrez M; Roda JM; Carceller F; Díez-Tejedor E
    J Neurol Sci; 2006 Sep; 247(2):121-9. PubMed ID: 16797595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombolysis compared with heparin for the initial treatment of pulmonary embolism: a meta-analysis of the randomized controlled trials.
    Wan S; Quinlan DJ; Agnelli G; Eikelboom JW
    Circulation; 2004 Aug; 110(6):744-9. PubMed ID: 15262836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Thrombolytic therapy in acute ischemic stroke. Critical analysis of current knowledge].
    Murray V; Norrving B; Terént A; Wester P
    Lakartidningen; 2004 Feb; 101(8):662-8, 670-3. PubMed ID: 15024939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interventional stroke therapy: the potential benefit of direct intra-arterial infusion.
    Connors JJ
    Rev Cardiovasc Med; 2002; 3 Suppl 2():S92-9. PubMed ID: 12556748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombolysis in aphemia.
    Shobha N; Smith EE
    N Z Med J; 2009 May; 122(1294):96-8. PubMed ID: 19465953
    [No Abstract]   [Full Text] [Related]  

  • 12. Desmoteplase.
    Paciaroni M; Medeiros E; Bogousslavsky J
    Expert Opin Biol Ther; 2009 Jun; 9(6):773-8. PubMed ID: 19456211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modern imaging of the infarct core and the ischemic penumbra in acute stroke patients: CT versus MRI.
    Ledezma CJ; Fiebach JB; Wintermark M
    Expert Rev Cardiovasc Ther; 2009 Apr; 7(4):395-403. PubMed ID: 19379068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment with melagatran alone or in combination with thrombolytic therapy reduced ischemic brain injury.
    Wang CX; Ding X; Shuaib A
    Exp Neurol; 2008 Sep; 213(1):171-5. PubMed ID: 18598697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recanalization and reperfusion therapies for acute ischemic stroke.
    Molina CA; Alvarez-Sabín J
    Cerebrovasc Dis; 2009; 27 Suppl 1():162-7. PubMed ID: 19342847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Technology Insight: recanalization with drugs and devices during acute ischemic stroke.
    Smith WS
    Nat Clin Pract Neurol; 2007 Jan; 3(1):45-53. PubMed ID: 17205074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterizing physiological heterogeneity of infarction risk in acute human ischaemic stroke using MRI.
    Wu O; Christensen S; Hjort N; Dijkhuizen RM; Kucinski T; Fiehler J; Thomalla G; Röther J; Østergaard L
    Brain; 2006 Sep; 129(Pt 9):2384-93. PubMed ID: 16891322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of antithrombotic drugs in older people.
    Tufano A; Cerbone AM; Di Minno G
    Minerva Med; 2002 Feb; 93(1):13-26. PubMed ID: 11850611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carboxypeptidase U (TAFIa) decreases the efficacy of thrombolytic therapy in ischemic stroke patients.
    Brouns R; Heylen E; Sheorajpanday R; Willemse JL; Kunnen J; De Surgeloose D; Hendriks DF; De Deyn PP
    Clin Neurol Neurosurg; 2009 Feb; 111(2):165-70. PubMed ID: 18980797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombolytic therapy for acute ischemic stroke: 3 h and beyond.
    Padma V; Fisher M; Moonis M
    Expert Rev Neurother; 2005 Mar; 5(2):223-33. PubMed ID: 15853492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.